Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson’s disease: insights from the French National Healthcare Data System (2015–2021)
Background and objectives Device-aided therapies (DAT) have significantly improved the management of Parkinson’s disease (PD). They now include deep brain stimulation (DBS), levodopa–carbidopa intestinal gel (LCIG) infusion, continuous subcutaneous apomorphine infusion (CSAI), subcutaneous foslevodo...
| Published in: | BMJ Neurology Open |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2026-05-01
|
| Online Access: | https://neurologyopen.bmj.com/content/8/1/e001577.full |